Skip to evidence report

GRNLSA.p53_damage: Studies — page 3

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 297 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 2,001–3,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for GRNLSA.p53_damage
#Trait / studyIndividual trait IDMean IC score
2001Chicken likingGCST900947326.62
2002VAT1 levelsGCST904710296.62
2003Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T412ECGU0004126.62
2004IDP dMRI ProbtrackX OD fmiGCST900044616.61
2005Clinical LDL cholesterol levelsGCST904972236.61
2006platelet count (minimum, inv-norm transformed)GCST904763026.60
2007Feeling nervousGCST0069486.60
2008Hearing aid user (UKB data field 3393)GCST900437416.60
2009Triacylglycerol_58:7_[M+NH4]1+ levelsGCST900605646.60
2010CRACR2A/IRAG2 ratioGCST903142276.59
2011Free Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005936.59
2012APLP1 levelsGCST904683306.59
2013F-deep fried food liking (derived food-liking factor)GCST900947536.59
2014Parental longevity (combined parental age at death)GCST0067026.59
2015Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T171ECGA0001716.59
2016ThalamNuclei rh volume PfGCST900027466.58
2017Recent trouble relaxing | AnxietyUKBB000007456.58
2018CMC1 levelsGCST904687946.57
2019Total lipid levels in large VLDLGCST900928746.57
2020IDP dMRI TBSS ICVF Cerebral peduncle LGCST900043426.57
2021CNTNAP2/DPP6 ratioGCST903141686.57
2022Triglycerides to Total Lipids in Very Small VLDL percentageGCST905008866.57
2023Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T398ECGU0003986.56
2024Triglyceride levels (MTAG)GCST901791496.56
2025Family history of certain disabilities and chronic diseases leading to disablement | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000002366.56
2026SNX2 levelsGCST904707016.56
2027TST levelsGCST904709826.56
2028Rhodanobacter abundance in stoolGCST900325366.56
2029Reticulocyte countGCST900024056.56
2030Triglyceride levels in very large VLDLGCST900930266.55
2031Cholesteryl Esters in Large LDLGCST904979496.55
2032Ever smoked | SmokingUKBB000002216.55
2033T1 FreeSurfer a2009s lh G precentral volumeGCST903848446.54
2034ICD10 N97.8: Female infertility of other originGCST904542256.54
2035PPP1R12A levelsGCST904703006.54
2036Joint pain (confirmatory factor analysis Factor 14)GCST903093486.53
2037Phospholipids to total lipids in very large VLDL percentage (UKB data field 23584)GCST902696816.53
2038Lamb likingGCST900947906.53
2039Blood cell traits latent factor 10 (platelet)GCST905592526.53
2040Sphingomyelins levelsGCST904999836.53
2041ACY1/DCXR ratioGCST903131626.52
2042Free cholesterol levels in chylomicrons and extremely large VLDLGCST900930446.52
2043BA-exvivo lh volume BA3bGCST900028386.52
2044Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T77ECGA0000776.51
2045Phospholipid levels in small VLDLGCST900929766.51
2046LAT levelsGCST904697416.50
2047Total lipids in medium LDL (UKB data field 23538)GCST902696356.50
2048X-25371 levelsGCST902006566.50
2049CHRDL1 levelsGCST904687506.50
2050End-diastolic bi-ventricular shape (principal component 1)GCST904484806.49
2051CD274 levelsGCST904686136.49
2052Polyunsaturated fatty acids to total fatty acids percentageGCST904992996.49
2053Right ventricular peak ejection rateGCST902681206.49
2054Saturated fatty acids to total fatty acids percentageGCST904999586.49
2055Total lipid levels in medium LDLGCST900929106.49
2056Apples likingGCST900946916.48
2057Chronic lung diseases including COPD, Emphysema and BronchitisGCST904752726.47
2058Phospholipids in medium LDL (UKB data field 23539)GCST902696366.47
2059IDP dMRI TBSS ICVF Superior corona radiata LGCST900043526.47
2060Fracture at wrist and hand levelFING000005516.46
2061RRM2B/SMAD1 ratioGCST903157886.46
2062DARS1/USP8 ratioGCST903144076.46
2063CD58/ROR1 ratioGCST903138546.45
2064Free cholesterol levels in very large VLDLGCST900930206.45
2065Worry too long after an embarrassing experienceGCST0069466.45
2066MGLL/PLA2G4A ratioGCST903154396.44
2067CNPY4/ERBIN ratioGCST903141486.44
2068Left-hemisphere control network to left-hemisphere default mode network white-matter structural connectivityGCST903027446.44
2069Other joint disordersFING000010646.44
2070Fruit likingGCST900947666.43
2071CRIM1/NRP2 ratioGCST903142616.43
2072Cholesterol to Total Lipids in Small HDL percentageGCST904993736.42
2073DTI TBSS MD Posterior corona radiata LGCST903845996.42
2074FCGR2B levelsGCST904692016.42
2075Triacylglycerol_46:5_[M+NH4]1+ levelsGCST900603566.42
2076CD302/CD99 ratioGCST903138056.42
2077LifespanGCST905518846.42
2078NUCB2/RSPO3 ratioGCST903155756.42
2079Cholesterol in Large HDLGCST904977196.41
2080Phosphatidylinositol-O_36:0_[M-H]1- levelsGCST900604806.40
2081Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T402ECGU0004026.40
2082CHMP1A/EREG ratioGCST903140486.40
2083T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 103)GCST903209226.39
2084Triglycerides to total lipids ratio in small HDLGCST900929556.39
2085ACP6 levelsGCST904682046.39
2086platelet count (mean, inv-norm transformed)GCST904762996.39
2087Cholesterol, totalGCST0007606.38
2088ASPN levelsGCST904683776.38
2089Cholesterol in large VLDL (UKB data field 23498)GCST902695956.38
2090Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T328ECGU0003286.38
2091DCXR/SCLY ratioGCST903144406.37
2092BTN2A1/IL18BP ratioGCST903135456.37
2093DRG2/SEMA4D ratioGCST903145546.37
2094Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T357ECGA0003576.36
2095HNMT/SETMAR ratioGCST903150696.36
2096Cholesteryl Esters in Large HDLGCST904977536.36
2097Cholesterol levels in chylomicrons and extremely large VLDLGCST905009186.36
2098Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levelsGCST900602776.35
2099NPY levelsGCST904700816.35
2100DARS1/MAP4K5 ratioGCST903144046.35
2101Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T226ECGU0002266.34
2102Concentration of LDL particles (UKB data field 23429)GCST902695266.34
2103Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T142ECGA0001426.34
2104ADGRE1 levelsGCST904682366.33
2105ANXA11 levelsGCST904683156.33
2106Triacylglycerol_50:3_[M+NH4]1+ levelsGCST900604686.33
2107Non-oily fish consumptionGCST901329946.33
2108Monounsaturated fatty acid levelsGCST905023476.33
2109Hemoglobin concentrationGCST900023116.33
2110low density lipoprotein cholesterol (LDLC, mean, inv-norm transformed)GCST904754166.32
2111DLL4 levelsGCST904690056.32
2112ITGA6 levelsGCST904696366.32
2113KIFBP levelsGCST904696836.31
2114Free cholesterol levels in small HDLGCST900929486.31
2115Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T22ECGA0000226.31
2116Pregnenediol disulfate (C21H34O8S2) levelsGCST901998406.30
2117Polyunsaturated fatty acid levelsGCST905026196.30
2118Parental longevity (combined parental attained age, Martingale residuals)GCST0066976.30
2119CLEC1B/LGALS8 ratioGCST903140966.29
2120DTI autoptx L3 fmi tractGCST903852046.29
2121Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T11ECGA0000116.28
2122ADGRE5/ITGB2 ratioGCST903131806.28
2123Cereal bar likingGCST900947286.28
2124Immature reticulocyte fraction (UKB data field 30280)GCST904680796.28
2125Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T82ECGA0000826.27
2126FABP5/PPCDC ratioGCST903147636.27
2127BCAM/SEMA7A ratioGCST903134766.27
2128IDP dMRI TBSS ICVF FornixGCST900043326.27
2129Total fatty acids levels (UKB data field 23442)GCST902695396.26
2130AAGAB levelsGCST906174736.26
2131Presence of other functional implants | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000007096.26
2132Triglycerides to Total Lipids in Very Large VLDL percentageGCST905006956.26
2133CLIP2/NT5C3A ratioGCST903141296.25
2134Left-hemisphere somatomotor network to left-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026716.23
2135Concentration of medium LDL particlesGCST900929116.23
2136PSCA levelsGCST904703526.23
2137CD200 levelsGCST904686066.22
2138Phosphatidylcholine-O_40:6_[M+H]1+/Phosphatidylcholine-P_40:5_[M+H]1+ levelsGCST900604206.22
2139Triacylglycerol_47:4_[M+NH4]1+ levelsGCST900603916.22
2140Phospholipids to Total Lipids in Very Large VLDL percentageGCST905006656.22
2141IGFBP2 levelsGCST904695286.21
2142Subclinical hyperthyroidism in pregnancyGCST904351996.21
2143CXCL1 levelsGCST904689306.21
2144ALB levelsGCST904751006.20
2145Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T97ECGU0000976.20
2146T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 112)GCST903209316.20
2147Concentration of large VLDL particlesGCST900928756.20
2148Immature reticulocyte fraction | Blood countUKBB000003556.20
2149Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T386ECGA0003866.19
2150Luteinizing hormone levelsGCST904834786.18
2151CTSF/SMPDL3A ratioGCST903143166.18
2152CTSZ/HSPG2 ratioGCST903143186.17
2153HYOU1/PTPRF ratioGCST903151026.17
2154Treatment/medication code - co-codamol | MedicationsUKBB000008456.17
2155Polyunsaturated fatty acids to total fatty acids percentageGCST904993026.16
2156Free cholesterol in medium LDLGCST904987746.16
2157TNFRSF14/TNFRSF1A ratioGCST903159356.16
2158aparc-a2009s rh volume S-centralGCST900030436.16
2159Diseases of sebaceous glands (PheCode 706)GCST904762106.16
2160Principal component-derived dietary pattern 13GCST901330186.15
2161IDP dMRI ProbtrackX ICVF ml lGCST900043926.15
2162Diacylglycerol_36:2_[M+H-H2O]1+ levelsGCST900601916.15
2163IDS/SMPDL3A ratioGCST903151266.13
2164Left-hemisphere limbic network to thalamus white-matter structural connectivityGCST903027366.13
2165Cholesterol to total lipids in large HDL percentage (UKB data field 23635)GCST902697326.13
2166BCR/ICA1 ratioGCST903134936.13
2167Monounsaturated fatty acids to total fatty acids percentageGCST905023856.13
2168Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T137ECGA0001376.11
2169Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T372ECGA0003726.11
2170ERBIN/SIRT2 ratioGCST903146966.11
2171CD58/IFNGR1 ratioGCST903138496.11
2172CTHRC1 levelsGCST904689026.10
2173Triglycerides in VLDLGCST905003046.09
2174HSPA1A levelsGCST904694876.09
2175Linoleic acid levelsGCST905023066.09
2176TNFSF8 levelsGCST904709236.09
2177aparc-pial rh area supramarginalGCST900032046.09
2178Cholesterol levels in very large VLDLGCST900930166.09
2179Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T383ECGA0003836.09
2180Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T368ECGA0003686.08
2181aparc-a2009s lh area Pole-temporalGCST900033396.08
2182KLKB1 levelsGCST904697086.08
2183AZU1/CEACAM8 ratioGCST903134246.08
2184Angina pectoris | circulatory systemUKBB000000306.08
2185LAYN/ULBP2 ratioGCST903152926.07
2186CPB1/KIRREL2 ratioGCST903142106.07
2187Myocardial fractal dimension (slice 2)GCST900002886.07
2188Triglycerides to total lipids ratio in medium HDLGCST900929036.07
2189CTSS levelsGCST904689166.06
2190Triglyceride levels in medium VLDLGCST900929266.06
2191IDP dMRI TBSS MD External capsule LGCST900040606.06
2192Other cancerGCST904751816.05
2193APP/DAG1 ratioGCST903133206.04
2194High light scatter reticulocyte countGCST0046116.04
2195Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T384ECGA0003846.04
2196CTSD/PRCP ratioGCST903143126.04
2197COL18A1/RETN ratioGCST903141706.04
2198CD40/CRELD2 ratioGCST903138116.04
2199Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T428ECGU0004286.03
2200HLA-DRA levelsGCST904694586.03
2201CASP3/CRKL ratioGCST903136316.03
2202Triglycerides to Total Lipids in Large LDL percentageGCST904981016.03
2203CLIP2/DAB2 ratioGCST903141246.02
2204Depression/anxiety (standard GWA)GCST902672766.02
2205GAS6 levelsGCST904693056.02
2206IDP T1 FAST ROIs R occ poleGCST900025466.01
2207Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T362ECGA0003626.01
2208DNAJA2/HPCAL1 ratioGCST903145036.01
2209CELA3A/CPB1 ratioGCST903140106.00
2210Citrate levelsGCST900928135.99
2211Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T16ECGA0000165.99
2212CRELD2/ERP44 ratioGCST903142535.99
2213Abdominal aortic aneurysm (AAA)FING000000015.98
2214ITGB1BP2/STAT5B ratioGCST903152205.98
2215Sleep disorders | Episodic and paroxysmal disordersUKBB000007755.97
2216IDP dMRI TBSS L3 Middle cerebellar peduncleGCST900041715.97
2217NIT1 levelsGCST904700505.97
2218Cholesterol to Total Lipids in Large VLDL percentageGCST904981305.96
2219MCAM/NTRK3 ratioGCST903154095.96
2220ThalamNuclei lh volume VAmcGCST900027235.96
2221Cholesteryl Esters to Total Lipids in Very Large VLDL percentageGCST905005655.96
2222Porridge likingGCST900948155.96
2223Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T381ECGA0003815.96
2224Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T133ECGA0001335.96
2225HRC levelsGCST904694755.96
2226IDP dMRI TBSS OD FornixGCST900044075.96
2227SCARA5 levelsGCST904705335.95
2228Total triglycerides levelsGCST900929925.95
2229Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2)GCST900440255.95
2230Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T247ECGU0002475.95
2231TBCC/WWP2 ratioGCST903159115.95
2232GP2/LGALS8 ratioGCST903149615.95
2233IGSF8/NECTIN2 ratioGCST903151405.95
2234IL10RB levelsGCST904695455.94
2235Monounsaturated fatty acid levelsGCST905023625.93
2236Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T180ECGU0001805.92
2237IDP dMRI TBSS MD Cingulum hippocampus LGCST900040645.92
2238PAMR1 levelsGCST904701555.92
2239IGFBP6/MFAP5 ratioGCST903151355.91
2240MOG/SEZ6L ratioGCST903154775.91
2241Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T374ECGA0003745.91
2242PEAR1/SNAP23 ratioGCST903156435.91
2243ITGB1/MCAM ratioGCST903152265.91
2244IDP dMRI TBSS ICVF Uncinate fasciculus RGCST900043715.91
2245Coriander likingGCST900947445.90
2246BCAN/NPTXR ratioGCST903134825.90
2247BSG/TNFRSF4 ratioGCST903135365.90
2248T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 63)GCST903208825.89
2249TMSB10/TRIAP1 ratioGCST903159245.89
2250Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T26ECGA0000265.89
2251JAM2/THBD ratioGCST903152395.88
2252Total fatty acid levelsGCST905027235.88
2253Phospholipids to Total Lipids in Medium VLDL percentageGCST904990445.88
2254IGF2R levelsGCST904695265.88
2255CST3/EFEMP1 ratioGCST903142925.88
2256Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T15ECGA0000155.88
2257Non-cancer illness code, self-reported - high cholesterol | Medical conditionsUKBB000005165.88
2258Moderate visual impairment, binocularFING000008315.87
2259BA-exvivo rh volume MTGCST900028605.87
2260Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T366ECGA0003665.86
2261Concentration of very small VLDL particlesGCST900930355.86
2262VSIR levelsGCST904710535.86
2263MIF levelsGCST904699065.85
2264aparc-pial lh area rostralmiddlefrontalGCST900031675.85
2265Total lipids in small HDL (UKB data field 23573)GCST902696705.85
2266SPON1 levelsGCST904707315.85
2267IDP dMRI TBSS FA Anterior limb of internal capsule LGCST900038945.85
2268DRG2 levelsGCST904690395.85
2269PDLIM7/PLA2G4A ratioGCST903156375.85
2270PLXNB3 levelsGCST904702675.84
2271Total lipid levels in very large VLDLGCST900930225.84
2272Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T367ECGA0003675.84
2273Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T371ECGA0003715.84
2274Free Cholesterol to Total Lipids in Small LDL percentageGCST904996355.83
2275Free cholesterol levels in small VLDLGCST900929725.83
2276ICAM2/IL7R ratioGCST903151175.83
2277IDP dMRI TBSS MD Cingulum cingulate gyrus LGCST900040625.83
2278Body mass indexGCST901037515.83
2279MATN2/SCARA5 ratioGCST903153885.81
2280DTI autoptx L3 ptr r tractGCST903852135.81
2281IDP dMRI TBSS L2 Superior cerebellar peduncle LGCST900041365.81
2282Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T385ECGA0003855.81
2283CXCL6/DFFA ratioGCST903143575.80
2284Polyunsaturated fatty acids to total fatty acids percentageGCST905026485.79
2285GP1BA levelsGCST904693805.79
2286AKR7L levelsGCST904682755.79
2287DTI autoptx L3 str l tractGCST903852165.79
2288Cholesterol levels in medium LDLGCST900929045.78
2289Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T53ECGA0000535.78
2290Phospholipid levels in very small VLDLGCST900930365.78
2291IDP dMRI ProbtrackX OD slf lGCST900044715.78
2292IDP dMRI TBSS ICVF Superior corona radiata RGCST900043515.78
2293HSPG2/PTGDS ratioGCST903150925.78
2294Chronic nephritic syndromeFING000002955.77
2295Concentration of very large VLDL particlesGCST905006315.76
2296GRHPR levelsGCST904694005.76
2297Diacylglycerol_34:2_[M+H-H2O]1+ levelsGCST900601785.76
2298ANG/F9 ratioGCST903132595.75
22991-palmitoyl-2-stearoyl-gpc (16:0/18:0) levelsGCST902000415.75
2300GAL levelsGCST900120625.75
2301Total lipids in very small VLDLGCST905008135.75
2302Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T373ECGA0003735.75
2303APOB levelsGCST902695365.75
2304Cholesteryl esters in large VLDL (UKB data field 23499)GCST902695965.75
2305CKAP2 levelsGCST902408665.75
2306Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T429ECGU0004295.73
2307Triglyceride levels (UKB data field 30870)GCST904681065.73
2308Linoleic acid to total fatty acids percentageGCST904983215.73
2309Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T410ECGU0004105.72
2310Hereditary ataxiaFING000006105.72
2311FCGR3B levelsGCST904692025.72
2312red cell diameter width (RDW, minimum, inv-norm transformed)GCST904763635.72
2313GLRX5 levelsGCST904693615.71
2314Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T110ECGA0001105.71
2315CDKN1A/ENO2 ratioGCST903139695.71
2316ROBO2/SCARF2 ratioGCST903157845.70
2317Concentration of very large VLDL particlesGCST900930235.70
2318Modified Stumvoll Insulin Sensitivity Index (adjusted for BMI)GCST902675735.70
2319Cholesteryl Esters to Total Lipids in Large VLDL percentageGCST904981655.70
2320COL5A1 levelsGCST904688205.69
2321Phospholipids in VLDLGCST905002685.69
2322LCAT levelsGCST904697455.69
2323IDP dMRI TBSS L1 Splenium of corpus callosumGCST900040795.68
2324Cereal type: Other (e.g. Cornflakes, Frosties) (UKB data field 1468_5)GCST901329735.68
2325Linoleic acid to total fatty acids percentageGCST904983285.68
2326Linoleic acid to total fatty acids percentageGCST905023365.67
2327Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T382ECGA0003825.67
2328Concentration of small LDL particlesGCST900929635.67
2329Cholesteryl ester levels in small LDLGCST900929585.66
2330Free cholesterol in IDLGCST904975645.66
2331Tea with sugar likingGCST900948575.65
2332Left bundle branch block (PheCode 426.32)GCST904759585.64
2333ThalamNuclei lh volume L-SgGCST900027165.64
2334EIF4G1/HEXIM1 ratioGCST903146355.63
2335CRTAC1 levelsGCST904688705.63
2336Total lipids in large LDLGCST904980215.63
2337FAP/LRRN1 ratioGCST903147835.62
2338Triglycerides to Total Lipids in Large VLDL percentageGCST904982935.62
2339Concentration of small HDL particlesGCST904994645.62
2340CRADD levelsGCST904688545.62
2341Phosphatidate_34:2_[M-H]1- levelsGCST900602235.62
2342ACAN levelsGCST904681965.61
2343ACHE levelsGCST904681995.61
2344Arthropathy in ulcerative colitisFING000001105.61
2345SH3BP1 levelsGCST904706195.61
2346Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T7ECGA0000075.60
2347GAPDH levelsGCST904693025.60
2348LDL (weighted GWA)GCST902672735.60
2349DTI autoptx L3 slf r tractGCST903852155.59
2350NUDT2 levelsGCST904701065.59
2351Osteoarthritis (hip)GCST0070915.59
2352Atherosclerosis of the extremities (PheCode 440.2)GCST904759905.58
2353CA12 levelsGCST904685075.58
2354Osteoarthritis of the hip or kneeGCST0070925.58
2355IFNGR1/IL10RB ratioGCST903151275.58
2356Cholesterol to Total Lipids in Large LDL percentageGCST904979295.58
235710-undecenoate (11:1n1) levelsGCST902435965.58
2358SUGT1 levelsGCST904707805.57
2359UBE2L6 levelsGCST904710015.57
2360IDI2 levelsGCST904695055.57
2361Concentration of medium LDL particlesGCST904988195.57
2362Current employment status - Doing unpaid or voluntary work | EmploymentUKBB000001575.57
2363Immature fraction of reticulocytesGCST900259715.57
2364CLEC1B/ITGB5 ratioGCST903140945.56
2365Free Cholesterol to Total Lipids in Large VLDL percentageGCST904982045.56
2366Total triglycerides levelsGCST905001265.56
2367Phosphatidylcholines levels (UKB data field 23437)GCST902695345.56
2368Concentration of very small VLDL particlesGCST905008265.56
2369Artrosis, including avohilmoFING000001125.55
2370triglyceride (minimum, inv-norm transformed)GCST904764395.55
2371Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T86ECGA0000865.55
2372EIF4E levelsGCST904690965.54
2373Monounsaturated fatty acid levelsGCST905023595.54
2374Phosphatidylcholine diacyl C38:3 levelsGCST902400455.53
2375T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 13)GCST903205765.53
2376Concentration of small VLDL particlesGCST900929755.53
2377Phospholipids to Total Lipids in Large VLDL percentageGCST904982525.53
2378Saturated fatty acids levelsGCST905026585.52
2379IDP dMRI TBSS ISOVF FornixGCST900044825.52
2380GPD1 levelsGCST904693885.52
2381LDLR levelsGCST901793465.52
2382Free Cholesterol in VLDLGCST905002175.51
2383Phosphatidylcholine-O_36:4_[M+H]1+/Phosphatidylcholine-P_36:3_[M+H]1+ levelsGCST900603185.51
2384Free cholesterol in VLDL (UKB data field 23420)GCST902695175.51
2385INSR levelsGCST902415095.51
2386Metabolic disordersFING000008165.49
2387PMM2 levelsGCST904702705.49
2388Acute pancreatitisGCST900185695.48
2389Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T387ECGA0003875.48
2390NeurociticismGCST0069405.48
2391CFH levelsGCST904687295.48
2392CD164/NUDT5 ratioGCST903137425.48
2393PECAM1 levelsGCST904702065.47
2394F5 levelsGCST904464665.47
2395BMI (standard GWA)GCST902672685.47
2396T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 111)GCST903206745.46
2397Abnormalities of forces of labourFING000000035.46
2398Platelet count (UKB data field 30080)GCST904680955.46
2399HippSubfield lh volume subiculum-bodyGCST900026695.45
2400Free cholesterol in small HDL (UKB data field 23577)GCST902696745.45
2401PSME1 levelsGCST904703605.45
2402BA-exvivo lh thickness BA2GCST900035145.45
2403Omega-3 fatty acids levelsGCST904991395.44
2404Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T175ECGU0001755.44
2405CD69/TXNDC5 ratioGCST903138895.44
2406Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T370ECGA0003705.44
2407Free cholesterol levels in large VLDLGCST900928725.43
2408Cholesteryl Esters to Total Lipids in Small VLDL percentageGCST904998005.43
2409Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T167ECGA0001675.43
2410SPINK5 levelsGCST904707245.43
2411Back pain | symptomsUKBB000000845.42
2412Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T397ECGU0003975.42
2413rfMRI amplitudes (ICA100 node 35)GCST900046235.42
2414PSRC1/SORT1 ratioGCST903157425.42
2415Triglycerides to Total Lipids in Large LDL percentageGCST904980925.42
2416NUBP1 levelsGCST904701005.41
2417TBCA levelsGCST904708125.41
2418Strawberries likingGCST900948495.41
2419DNAJA2/HCLS1 ratioGCST903145025.40
2420INPP1/TBCC ratioGCST903151805.40
2421Total lipids in very large VLDLGCST905006145.40
2422Clonal haematopoiesis of indeterminate potential (ASXL1 mutation)GCST901652595.39
2423APP/NID1 ratioGCST903133265.39
2424Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T363ECGA0003635.39
2425ITIH3/VCAM1 ratioGCST903152365.38
2426CNTN4 levelsGCST904688065.38
2427Phospholipid levels in medium LDLGCST900929125.38
2428IDP dMRI TBSS ISOVF External capsule RGCST900045095.38
2429Cholesterol to Total Lipids in IDL percentageGCST904975185.38
2430Degree of unsaturationGCST905027525.37
2431Total lipid levels in small VLDLGCST900929745.37
2432Cerebrospinal fluid S-1-pyrroline-5-carboxylate levelsGCST903182355.36
2433CST3/IL18BP ratioGCST903142945.36
2434Illnesses of father - Heart disease | Family historyUKBB000003425.36
2435Sphingomyelin_41:0_[M+H]1+ levelsGCST900603865.36
2436Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24)GCST903093585.35
2437Cholesteryl Esters to Total Lipids in IDL percentageGCST904975495.35
2438Glycoprotein acetyls levelsGCST904973285.35
2439GP6/LGALS8 ratioGCST903149645.35
2440CD84 levelsGCST904686535.35
2441PNLIPRP2 levelsGCST904702745.34
2442PCDH12 levelsGCST904701685.34
2443aparc-pial lh area TotalSurfaceGCST900031415.33
2444triglyceride (mean, inv-norm transformed)GCST904764355.33
2445FCN1 levelsGCST904692035.33
2446STIP1 levelsGCST904707645.33
2447Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T245ECGU0002455.33
2448Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T400ECGU0004005.32
2449Total lipid levels in very small VLDLGCST900930345.31
2450GC levelsGCST901625645.31
2451COL3A1 levelsGCST904688175.31
2452Phosphatidylcholine levelsGCST900929375.30
2453NUB1/SRPK2 ratioGCST903155735.30
2454HMOX2/TDRKH ratioGCST903150675.30
2455ENPP7 levelsGCST904691185.29
2456MGMT levelsGCST904699025.29
2457Omega-6 fatty acid levelsGCST905025145.29
2458Angina pectoris (PheCode 411.3)GCST904759335.28
2459Leucine levelsGCST900928915.28
2460MMP9/OLR1 ratioGCST903154675.27
2461RELT/TNFRSF1A ratioGCST903157675.27
2462Platelet countGCST900024025.27
2463Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T401ECGU0004015.27
2464Liver fatGCST900290735.27
2465CDH5/PCDH17 ratioGCST903139585.26
2466Urine glucuronide of C10H18O2 (12)* levels in chronic kidney diseaseGCST902651895.25
2467Cholesterol in small LDL (UKB data field 23547)GCST902696445.25
2468MAP2K6/MGMT ratioGCST903153735.25
2469IDP dMRI ProbtrackX ICVF cgh lGCST900043815.24
2470Total lipids in medium VLDLGCST904989945.24
2471Triacylglycerol_54:4_[M+NH4]1+ levelsGCST900605405.24
2472IDP dMRI TBSS FA FornixGCST900038825.24
2473DAPP1 levelsGCST904689465.23
2474Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T256ECGU0002565.23
2475Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T177ECGU0001775.23
2476Left-hemisphere somatomotor network to left-hemisphere default mode network white-matter structural connectivityGCST903026745.23
2477IDP dMRI ProbtrackX ICVF ilf rGCST900043905.23
2478Other functional intestinal disordersFING000010525.23
2479aseg global volume SupraTentorialNotVentGCST900025965.22
2480Recent feelings or nervousness or anxiety | AnxietyUKBB000007415.22
2481Congestive heart failureGCST904752005.21
2482HNRNPK levelsGCST904694695.21
24831-linoleoyl-GPI (18:2) levelsGCST901998215.21
2484Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T229ECGU0002295.21
2485CD99L2/RARRES2 ratioGCST903139275.21
2486Retinal thickness (functional principal component 4)GCST904557245.20
2487Phospholipid levels in very large VLDLGCST900930245.20
2488Blood cell traits latent factor 14 (red cell)GCST905592565.20
2489IDP dMRI TBSS MD FornixGCST900040325.19
2490Omega-6 fatty acid levelsGCST905025185.19
2491Other strabismusFING000011145.19
2492Diacylglycerol_36:3_[M+H-H2O]1+ levelsGCST900601895.19
2493KDR levelsGCST902433235.18
2494Monounsaturated fatty acid levelsGCST904990945.18
2495Sitting height | Body size measuresUKBB000007715.18
2496ARHGEF10 levelsGCST904683575.18
2497FKBP5/MAP4K5 ratioGCST903148435.18
2498Linoleic acid levelsGCST905020045.17
2499APBB1IP/POLR2F ratioGCST903133005.17
2500aseg global volume VentricleChoroidGCST900025985.17
2501CD177 levelsGCST904686035.16
2502Left-hemisphere salience/ventral attention network to left-hemisphere default mode network white-matter structural connectivityGCST903027115.16
2503SORD levelsGCST904707095.15
2504Hereditary corneal dystrophiesFING000006115.15
2505Non-oily fish intake | DietUKBB000005255.14
2506Cholesteryl esters in VLDL (UKB data field 23416)GCST902695135.14
2507Illness, injury, bereavement, stress in last 2 years - Financial difficulties | Mental healthUKBB000003385.14
2508Concentration of small VLDL particlesGCST904998565.14
2509BLVRB/HBQ1 ratioGCST903135255.14
2510CFI levelsGCST904687305.14
2511Alkaline phosphatase | Blood biochemistryUKBB000000275.14
2512Concentration of LDL particlesGCST900928875.14
2513Liver condition (ex. cirrhosis)GCST904752705.14
2514Phlebitis and thrombophlebitis (PheCode 451)GCST904760035.13
2515HDL cholesterolGCST900187365.13
2516Monounsaturated fatty acid levelsGCST904990905.13
2517Liver enzyme levels (alkaline phosphatase)GCST900134065.13
2518CRELD2/TXNDC5 ratioGCST903142595.13
2519FGF19 levelsGCST904692205.12
2520Malignant neoplasm of liver, primary (PheCode 155.1)GCST904755695.12
2521Red blood cell countGCST900023645.12
2522VLDL cholesterol levels (UKB data field 23403)GCST902695005.12
2523aparc-a2009s rh volume S-oc-middle+LunatusGCST900030555.12
2524SMAD1/ZBTB16 ratioGCST903158535.12
2525ITGB1/NCAM1 ratioGCST903152275.12
2526Frailty (Factor 4 - Metabolic Problems)GCST906240505.11
2527Omega-3 fatty acid levelsGCST905020645.11
2528aparc-DKTatlas lh thickness precentralGCST900035625.11
2529Saturated fatty acids levelsGCST905021945.10
2530Body fat percentage (adjusted for testosterone and SHBG)GCST904321795.10
2531Retinoschisis and retinal cysts (PheCode 361.2)GCST904758465.10
2532PLAU/PLAUR ratioGCST903156745.09
2533Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T407ECGU0004075.09
2534GAL/PM20D1 ratioGCST903149175.08
2535CA13/TIA1 ratioGCST903135675.08
2536Carnitine levelsGCST902399915.08
2537MSRA/PRDX5 ratioGCST903154975.08
2538TACSTD2 levelsGCST904707985.07
2539Free cholesterol levels in very small VLDLGCST900930325.07
2540IDP dMRI ProbtrackX ICVF str rGCST900043995.07
2541aseg lh volume Lateral-VentricleGCST900026165.07
2542Monounsaturated fatty acid levelsGCST905023465.06
2543FUS levelsGCST904692785.06
2544platelet count (maximum, inv-norm transformed)GCST904762965.06
2545Age-related hearing impairment (MTAG)GCST900121155.06
2546BA-exvivo lh volume BA6GCST900028415.06
2547Abdominal pain | symptomsUKBB000000035.06
2548DTI autoptx MD cgc r tractGCST903852255.05
2549CPA1 levelsGCST904688365.05
2550IDP dMRI TBSS ISOVF Anterior corona radiata RGCST900044995.05
2551TDRKH/TST ratioGCST903159135.05
2552DCTN1/ERBIN ratioGCST903144295.05
2553CAG-177 abundance in stoolGCST900322615.05
2554Right-hemisphere salience/ventral attention network to hippocampus white-matter structural connectivityGCST903028215.05
2555ASPSCR1 levelsGCST904683785.05
2556TDP1 levelsGCST904708265.05
2557CD164/PARK7 ratioGCST903137435.04
2558CDKN1A/FOXO1 ratioGCST903139705.04
25591-arachidonoylglycerophosphocholine levelsGCST902436745.04
2560IDP dMRI TBSS FA Posterior limb of internal capsule LGCST900038965.04
2561Wegener granulomatosisFING000014465.03
2562Sleep disorders | neurologicalUKBB000007765.03
2563LBR/LGALS8 ratioGCST903152945.03
2564Anterior thigh muscle volumeGCST902673495.03
2565CDKN1A/DAB2 ratioGCST903139675.03
2566aparc-Desikan lh thickness precentralGCST900034685.02
2567Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T369ECGA0003695.01
2568Concentration of large VLDL particlesGCST904982235.00
2569Ascending aorta diameterGCST900910505.00
2570AMY1A or AMY1B or AMY1C levelsGCST904682975.00
2571PEPD levelsGCST904702095.00
2572Concentration of medium VLDL particlesGCST904990175.00
2573Triglycerides to Total Lipids in Small VLDL percentageGCST904999225.00
2574Paracetamol of NSAID medicationFING000011455.00
2575MIA/NBL1 ratioGCST903154454.99
2576F13B levelsGCST904691674.99
2577Triglycerides to Total Lipids in IDL percentageGCST904976764.99
2578Monounsaturated fatty acids to total fatty acids percentageGCST904991094.99
2579IDP dMRI TBSS FA Uncinate fasciculus LGCST900039224.99
2580ANXA1 levelsGCST904683164.99
2581IDP T1 SIENAX CSF normalised volumeGCST900024284.98
2582Thoracic or lumbosacral neuritis or radiculitis, unspecified (PheCode 763)GCST904762684.98
2583Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levelsGCST902000984.98
2584Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T105ECGU0001054.97
2585MUC16 levelsGCST904699644.97
2586PTPRF/SDC1 ratioGCST903157524.97
2587Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T339ECGU0003394.96
2588ROBO1 levelsGCST904704894.95
2589IPCEF1/TBCB ratioGCST903151874.95
2590Cholesterol in medium LDL (UKB data field 23540)GCST902696374.95
2591Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T336ECGU0003364.95
2592Diastolic blood pressure, manual reading | Blood pressureUKBB000001804.94
2593FAM3C/NECTIN2 ratioGCST903147814.94
2594COL6A3/OGN ratioGCST903141774.94
2595Triglyceride to phosphoglyceride ratioGCST904999924.93
2596Saturated fatty acids to total fatty acids percentageGCST905022074.93
2597DPP6/SEZ6L ratioGCST903145444.92
2598Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levelsGCST900602984.92
2599Triacylglycerol_52:5_[M+NH4]1+ levelsGCST900605064.92
2600FCN2 levelsGCST904692044.91
2601SNAP25 levelsGCST904706914.90
2602CASP3/SERPINB9 ratioGCST903136424.90
2603TNFRSF12A levelsGCST904709044.90
2604FOLR3 levelsGCST904692614.89
2605red cell diameter width (RDW, minimum, inv-norm transformed)GCST904763654.89
2606IL6ST/PDGFRA ratioGCST903151694.89
2607TNFSF10 levelsGCST904709174.89
2608CETN2/PRTFDC1 ratioGCST903140304.88
2609SPART levelsGCST904707194.88
2610PCDH17/THBD ratioGCST903156074.88
2611PCBP2 levelsGCST904701674.88
2612Proline levelsGCST902434574.88
2613PPM1B levelsGCST904702964.88
2614Whole grain cereal likingGCST900948694.88
2615Phospholipid levels in large VLDLGCST900928764.87
2616F3 levelsGCST904691704.87
2617ThalamNuclei lh volume PuIGCST900027144.87
2618Total free cholesterol levelsGCST905000724.87
2619IL1RL2 levelsGCST904695754.87
2620aparc-a2009s rh volume S-subparietalGCST900030694.87
2621IDP dMRI TBSS L3 Cerebral peduncle RGCST900041854.86
2622RGMB/THY1 ratioGCST903157714.86
2623Cerebrospinal fluid beta-hydroxyisovaleroylcarnitine levelsGCST903180134.86
2624FAM171B levelsGCST900903394.86
2625Omega-6 fatty acid levelsGCST905025154.85
2626rfMRI connectivity (ICA100 edge 931)GCST900057844.85
2627NPL levelsGCST904700724.84
2628Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T179ECGU0001794.84
2629SCARF2 levelsGCST904705374.84
2630SH2B3/SUGT1 ratioGCST903158404.84
2631Multi-trait sum scoreGCST902701194.84
2632ALDH1A1/RBKS ratioGCST903132474.84
2633LTA4H levelsGCST904698124.83
2634FOLR2 levelsGCST904692604.83
2635IGF1 levelsUKBB000003374.83
2636Metabolic disorder, other/unspecifiedFING000008154.82
2637Phospholipids to Total Lipids in Very Small VLDL percentageGCST905008664.82
2638Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T166ECGA0001664.81
2639IDP SWI T2star left putamenGCST900038674.81
2640HSPB1/PLIN3 ratioGCST903150884.80
2641IL6ST/LEPR ratioGCST903151654.80
2642LAT2 levelsGCST904697394.80
2643Other diseases of the digestive systemFING000010104.79
2644BA-exvivo rh area BA4pGCST900032264.79
2645IDP T1 FIRST right putamen volumeGCST900024414.79
2646CHRDL1/SMOC2 ratioGCST903140624.78
2647Linoleic acid levelsGCST905022954.78
2648Chronic airway obstruction | respiratoryUKBB000001354.78
2649CPB1/PRSS2 ratioGCST903142114.77
2650Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T27ECGA0000274.77
2651Phospholipids in LDLGCST904984394.77
2652CD200R1 levelsGCST904686054.77
2653CGREF1 levelsGCST904687354.77
2654Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T318ECGU0003184.77
2655IDP T1 SIENAX CSF unnormalised volumeGCST900024294.76
2656FADD levelsGCST904691804.76
2657SMAD5 levelsGCST904706784.76
2658ATRN levelsGCST904684004.76
2659Monounsaturated fatty acids to total fatty acids percentageGCST904991114.76
2660TNFSF12 levelsGCST904709194.75
2661Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T406ECGU0004064.75
2662Cholesterol levels in large VLDLGCST900928684.75
2663CNTN3 levelsGCST904688054.75
2664Number in household | HouseholdUKBB000005304.74
2665IDP dMRI TBSS ICVF Cingulum hippocampus LGCST900043644.74
2666Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T169ECGA0001694.74
2667CXCL11/CXCL13 ratioGCST903143334.74
2668FCRL2/KLB ratioGCST903147984.74
2669Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T126ECGU0001264.73
2670IDP dMRI ProbtrackX MD ptr rGCST900042394.73
2671Polyunsaturated fatty acid levelsGCST905026064.73
2672KIRREL2 levelsGCST904696904.73
2673Obstructive chronic bronchitis | respiratoryUKBB000005464.73
2674Chronic bronchitis | respiratoryUKBB000001364.72
2675Syncope and collapse | symptomsUKBB000008014.72
2676REG1A/REG4 ratioGCST903157624.72
2677AREG levelsGCST904683474.72
2678Myocardial infarctionGCST900186574.72
2679CX3CL1 levelsGCST902747784.71
2680aparc-DKTatlas lh volume rostralmiddlefrontalGCST900028874.71
2681CNTNAP2 levelsGCST904688084.71
2682DTI TBSS MD Retrolenticular part of internal capsule RGCST903845924.71
2683Cholesteryl Esters to Total Lipids in Large VLDL percentageGCST904981624.70
2684CCL25 levelsGCST902747684.70
2685Principal component-derived dietary pattern 28GCST901330334.70
2686AmygNuclei lh volume Central-nucleusGCST900026524.70
2687ACP5 levelsGCST904682034.70
2688PLAUR levelsGCST904702514.70
2689KLK13 levelsGCST904696994.69
2690Mean corpuscular hemoglobinGCST900023234.69
2691Waist circumferenceGCST901037534.68
2692BLMH levelsGCST904684474.68
2693DNAJC9 levelsGCST904690184.68
2694IDP dMRI TBSS MD Middle cerebellar peduncleGCST900040274.68
2695FAM172A levelsGCST904691844.68
2696Fatty acid(20:3)_[M-H]1- levelsGCST900601174.68
2697Total fatty acid levelsGCST905000534.68
2698Cholesterol to Total Lipids in Large VLDL percentageGCST904981254.67
2699X-11787 levelsGCST902004654.67
2700Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T21ECGA0000214.67
2701CD40LG/SERPINE1 ratioGCST903138264.67
2702IRAK4 levelsGCST904696284.67
2703FCGR2B/NOS3 ratioGCST903147944.67
2704CNDP1/F9 ratioGCST903141474.67
2705Concentration of medium LDL particles (UKB data field 23537)GCST902696344.67
2706Operation code - spine or back surgery | OperationsUKBB000005654.66
2707IDP dMRI TBSS L2 Cerebral peduncle RGCST900041374.66
2708Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T282ECGA0002824.66
2709CTRC levelsGCST904689064.66
2710BA-exvivo rh area perirhinalGCST900032334.66
2711Miserableness | Mental healthUKBB000004784.66
2712Plasma sulfate of piperine metabolite C18H21NO3 (1)* levels in chronic kidney diseaseGCST902660164.65
2713Left ventricular end diastolic mass end diastolic volume ratioGCST902681314.65
2714Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T87ECGA0000874.65
2715Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T355ECGA0003554.65
2716Physical activity (Total log acceleration 2am-4am)GCST900614104.65
2717Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T132ECGA0001324.65
2718CPPED1 levelsGCST904688454.65
2719PODXL levelsGCST904702804.65
2720Alkenylphosphatidylethanolamine (P-20:0/18:2) levelsGCST900250564.64
2721Total phospholipid levels in lipoprotein particlesGCST905001244.64
2722APP/EGF ratioGCST903133224.64
2723Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T18ECGA0000184.64
2724Total lipids in small VLDLGCST904998404.64
2725Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T48ECGA0000484.64
2726Experiencing mood swingsGCST0069444.64
2727AHSA1 levelsGCST904682624.64
2728Low-density lipoprotein levels (MTAG)GCST901791484.64
2729ThalamNuclei rh volume VLpGCST900027554.63
2730Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T228ECGU0002284.63
2731Triglyceride levels in very small VLDLGCST901326694.62
2732Cataract (PheCode 366)GCST900437854.62
2733Aortic aneurysm (PheCode 442.1)GCST904759934.62
2734Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T173ECGA0001734.62
2735aseg global volume BrainSegNotVentSurfGCST900025924.62
2736EGFLAM levelsGCST904690844.62
2737VPS4B levelsGCST904710474.62
2738AHSP/HMBS ratioGCST903132174.62
2739DAPP1/PMVK ratioGCST903143964.62
2740Platelet count | Blood countUKBB000006464.62
2741End-diastolic bi-ventricular shape (principal component 3)GCST904484824.62
2742Hemangioma of skin and subcutaneous tissue (PheCode 228.1)GCST904756334.61
2743TBCC levelsGCST904708144.61
2744Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T225ECGU0002254.61
2745Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T490ECGA0004904.61
2746Pain in jointFING000011374.61
2747aparc-pial lh area lateraloccipitalGCST900031514.61
2748Mean corpuscular hemoglobinGCST0046304.61
2749Phosphatidylcholine-O_38:5_[M+H]1+/Phosphatidylcholine-P_38:4_[M+H]1+ levelsGCST900603754.61
2750CBLN4/RET ratioGCST903136604.60
2751Omega-3 fatty acids levelsGCST904991454.60
2752Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T87ECGU0000874.60
2753CIAPIN1/PLA2G4A ratioGCST903140654.59
2754BA-exvivo lh volume entorhinalGCST900028484.59
2755PDGFB levelsGCST900120164.59
2756STMN3 levelsGCST902428944.59
2757Monounsaturated fatty acids to total fatty acids percentageGCST905023734.59
2758Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T326ECGU0003264.58
2759GPHA2 levelsGCST904693894.58
2760GoutFING000005874.57
2761ALB levelsGCST900259924.57
2762CD163/MSR1 ratioGCST903137384.57
2763Platelet countGCST902786404.57
2764Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T388ECGA0003884.56
2765IDP dMRI TBSS L3 FornixGCST900041764.56
2766AMIGO2 levelsGCST904682924.56
2767Concentration of large LDL particlesGCST900928634.56
2768High light scatter reticulocyte countGCST900023854.55
2769Blood clot / pulmonary embolism / deep vein thrombosis (DVT)GCST904752094.55
2770Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T359ECGA0003594.55
2771FBP1/GSTA1 ratioGCST903147864.54
2772RFC4 levelsGCST904704604.54
2773Total lipids in small HDLGCST904994564.54
2774Fed-up feelings | Mental healthUKBB000002424.54
2775Phospholipids to Total Lipids in Small VLDL percentageGCST904999024.54
2776PCDH9 levelsGCST904701724.54
2777Polyunsaturated fatty acid levelsGCST905026074.53
2778Osteoarthrosis NOS | musculoskeletalUKBB000005974.53
2779IDP dMRI ProbtrackX L2 ar lGCST900042734.53
2780GLB1 levelsGCST904693554.53
2781CRADD/FKBP4 ratioGCST903142384.52
2782Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T49ECGA0000494.52
2783Left ventricular end diastole inferoseptal wall thicknessGCST902785144.52
2784Total lipids in large VLDLGCST904982164.52
2785Left-hemisphere limbic network to hippocampus white-matter structural connectivityGCST903027404.52
2786Parental longevity (father's age at death)GCST0067004.52
2787ACVRL1/TNFRSF19 ratioGCST903131594.52
2788Saturated fatty acids to total fatty acids percentageGCST904999664.52
2789Free cholesterol in medium VLDL (UKB data field 23507)GCST902696044.52
2790Reticulocyte countGCST900259724.52
2791Dihexosylceramide (d18:1/24:0) levelsGCST900253494.51
2792SPARCL1 levelsGCST904707174.50
2793CCL13/CCL8 ratioGCST903136764.50
2794MCFD2 levelsGCST904698734.50
2795Other arthrosisFING000009654.50
2796CMIP levelsGCST904687954.49
2797GSTT2B levelsGCST904694154.49
2798BAG6/USP8 ratioGCST903134514.49
2799Total Lipids in VLDLGCST905002344.48
2800Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T248ECGU0002484.48
2801GPA33 levelsGCST904693854.48
2802Sphingomyelin_40:0_[M+H]1+ levelsGCST900603644.47
2803Triacylglycerol (54:2) [NL-18:0] levelsGCST900251754.47
2804CPA1/PRSS2 ratioGCST903142064.47
2805C1S levelsGCST904684944.47
2806Platelet distribution widthGCST0046164.47
2807Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T390ECGU0003904.47
2808Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T411ECGU0004114.46
2809Triacylglycerol_54:7_[M+NH4]1+ levelsGCST900605364.46
2810Cholesteryl Esters to Total Lipids in Large LDL percentageGCST904979694.46
2811APOB levelsGCST900928094.46
2812IDP dMRI TBSS ICVF Superior cerebellar peduncle RGCST900043394.46
2813Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T6ECGA0000064.45
2814Free cholesterol in medium LDL (UKB data field 23542)GCST902696394.45
2815ELAC1 levelsGCST904691014.45
2816total cholesterol (minimum, inv-norm transformed)GCST904764274.45
2817PlateletcritGCST900024004.45
2818IL16/NADK ratioGCST903151524.45
2819LTBP3 levelsGCST904698154.45
2820IDP dMRI TBSS ICVF Middle cerebellar peduncleGCST900043274.44
2821HematocritGCST900023054.44
2822HemoglobinGCST902786314.44
2823Carotid plaqueGCST0074354.44
2824Facial skin colour (CIELAB index b* value)GCST900200564.43
2825EFNB2 levelsGCST904690824.43
2826Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T168ECGA0001684.43
2827Body fat percentageGCST0070644.43
2828Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T88ECGA0000884.43
2829aparc-DKTatlas rh volume lateraloccipitalGCST900029024.42
2830Hearing aid user | HearingUKBB000003094.42
2831CDKN1A/NCK2 ratioGCST903139734.42
2832Cholesteryl esters to total lipids in large HDL percentage (UKB data field 23636)GCST902697334.41
2833Follicular cysts of skin and subcutaneous tissueFING000005474.41
2834Bundle branch block (PheCode 426.3)GCST904759564.41
2835Cooked vegetables consumptionGCST901329774.41
2836Ratio of triglycerides to phosphoglyceridesGCST900929834.41
2837Loud music exposure frequency | HearingUKBB000004104.40
2838Total lipids in medium VLDL (UKB data field 23503)GCST902696004.39
28394-acetamidobutanoate levelsGCST902434404.39
2840ITGB5/VSIR ratioGCST903152354.39
2841NMNAT1 levelsGCST904700574.39
2842Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T285ECGA0002854.39
28431-(1-enyl-palmitoyl)-2-linoleoyl-GPE (p-16:0/18:2) levelsGCST902000754.39
2844CLTA levelsGCST904687914.39
2845Remnant cholesterol (non-HDL, non-LDL -cholesterol)GCST904993354.38
2846Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T360ECGU0003604.38
2847PlateletcritGCST0046074.38
2848CTSC/PLA2G15 ratioGCST903143114.38
2849DTI autoptx L2 ilf r tractGCST903851814.38
2850LAMP1 levelsGCST904697334.38
2851F9/FURIN ratioGCST903147474.38
2852rfMRI amplitudes (ICA100 node 45)GCST900046334.38
2853HDL cholesterolGCST0007554.38
2854Asphyxia and hypoxemia (PheCode 1013)GCST904755594.38
2855aseg global volume CC-PosteriorGCST900026074.37
2856Non-cancer illness code, self-reported - kidney stone/ureter stone/bladder stone | Medical conditionsUKBB000005194.37
2857High light scatter reticulocyte percentage of red cellsGCST900023864.37
2858LILRB1 levelsGCST904697764.37
28591-methylhistidine levelsGCST901996914.37
2860IDP dMRI TBSS ICVF Anterior corona radiata LGCST900043504.37
2861aparc-Desikan rh volume parahippocampalGCST900028164.37
2862Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T338ECGA0003384.36
2863P4HB/PPP1R12A ratioGCST903155914.36
2864Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T29ECGA0000294.36
2865Other forms of systemic lupus erythematosusFING000010514.35
2866Hippocampal right GC-ML-DG volume (head)GCST902679684.35
2867T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60)GCST903206234.35
2868Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T131ECGU0001314.35
2869Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T176ECGA0001764.34
28701-arachidonoylglycerophosphoethanolamine levelsGCST902438084.34
2871Reaction timeGCST0034994.34
2872NMT1 levelsGCST904700594.34
2873CA4/SELE ratioGCST903135874.34
2874Treatment speciality of consultant (recoded) - Trauma & orthopaedics | Summary AdministrationUKBB000008374.33
2875ArthrosisFING000001114.33
2876Plum likingGCST900948124.33
2877Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T20ECGA0000204.33
2878aseg global volume CSFGCST900026034.33
2879Arterial embolism and thrombosis of lower extremity arteryFING000001064.33
2880FRZB levelsGCST904692694.33
2881Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T207ECGU0002074.32
2882Rotator cuff syndromeFING000012704.32
2883Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T365ECGA0003654.32
2884Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2)GCST904760044.32
2885Cholesterol to total lipids ratio in large HDLGCST900928454.32
2886Phospholipids in medium VLDL (UKB data field 23504)GCST902696014.32
2887Triacylglycerol_52:2_[M+NH4]1+ levelsGCST900605114.32
2888CRNN levelsGCST902778904.32
2889SERPINE1/SPARC ratioGCST903158344.31
2890Age started wearing glasses or contact lenses | EyesightUKBB000000174.31
2891TNC levelsGCST904708954.31
2892PACS2 levelsGCST904701414.31
2893GLOD4/HSPA1A ratioGCST903149374.31
2894Serum copper levelsGCST901005244.31
2895Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T364ECGA0003644.31
2896Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T415ECGU0004154.31
2897Body fat percentageGCST901037524.30
2898Type of accommodation lived in - A house or bungalow | HouseholdUKBB000008694.30
2899Total Lipids in VLDLGCST905002364.29
2900MPHOSPH8 levelsGCST904699344.29
2901GFER/VASH1 ratioGCST903149224.29
2902aseg global volume EstimatedTotalIntraCranialGCST900025974.29
2903Other hearing lossFING000010564.29
2904IDP dMRI TBSS L3 Sagittal stratum LGCST900042024.28
2905ThalamNuclei rh volume MDlGCST900027484.28
2906PRAP1 levelsGCST904703124.28
2907SRPX levelsGCST904707444.28
2908ADGRE2/IFNGR1 ratioGCST903131774.27
2909Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T356ECGA0003564.27
2910CASP3 levelsGCST904685454.27
2911BMI (weighted GWA)GCST902672694.27
2912Pregnenetriol sulfate levelsGCST902002414.27
2913PPP1R2 levelsGCST904703044.26
2914F-meat liking (derived food-liking factor)GCST900947994.26
2915IL6ST/LIFR ratioGCST903151664.26
2916Androstenediol (3beta,17beta) monosulfate (1) levelsGCST901998724.26
2917CST6/GAL ratioGCST903143024.25
2918IDP dMRI TBSS OD Anterior limb of internal capsule RGCST900044184.25
2919Mood [affective] disordersFING000008364.25
2920LY75 levelsGCST904698224.25
2921Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007164.25
2922Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T361ECGA0003614.25
2923IDP dMRI TBSS L1 Cingulum cingulate gyrus RGCST900041094.25
2924COL1A1 levelsGCST904688134.25
2925ROBO2 levelsGCST904704904.24
2926CASP10/ING1 ratioGCST903136254.24
2927Platelet crit | Blood countUKBB000006474.24
2928PDGFB levelsGCST904701894.24
2929Other diseases of urinary systemFING000010134.24
2930HippSubfield lh volume Whole-hippocampusGCST900026894.23
2931Disorders of lipoprotein metabolism and other lipidaemias | Metabolic disordersUKBB000001864.23
2932CD79B/CKAP4 ratioGCST903138984.23
2933Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T349ECGA0003494.23
2934Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T127ECGU0001274.23
2935COLEC12/TNFRSF1A ratioGCST903141874.23
2936BCR/PLXNA4 ratioGCST903134974.23
2937Disorders of lipoid metabolism | endocrine/metabolicUKBB000001854.22
2938Polyneuropathy in diabetes (PheCode 250.6)GCST904756864.22
2939Free cholesterol to total lipids in small HDL percentage (UKB data field 23647)GCST902697444.22
2940CKAP4 levelsGCST904687584.22
2941Hyperlipidemia | endocrine/metabolicUKBB000003334.21
2942Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T389ECGA0003894.21
2943triglyceride (minimum, inv-norm transformed)GCST904764374.21
2944Lysophosphatidylcholine (26:0) [sn1] levelsGCST900241884.21
2945IL32 levelsGCST904695914.21
2946Triacylglycerol_52:1_[M+NH4]1+ levelsGCST900605154.21
2947SEMA4D/TXNDC5 ratioGCST903158244.20
2948Free Cholesterol to Total Lipids in Small VLDL percentageGCST904998314.20
2949BA-exvivo lh area entorhinalGCST900032204.20
2950AMY2A levelsGCST904682984.19
2951Cholesteryl Esters to Total Lipids in Very Small VLDL percentageGCST905007544.19
2952IDP dMRI ProbtrackX ICVF ar lGCST900043754.19
2953Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T181ECGU0001814.19
2954Other chronic obstructive pulmonary disease | Chronic lower respiratory diseasesUKBB000006044.19
2955Nonalcoholic fatty liver diseaseFING000008784.19
2956TNFSF11 levelsGCST900120444.19
2957Mineral and other dietary supplements - Zinc | MedicationUKBB000004764.18
2958FKBP5 levelsGCST904692444.18
2959Takes medication for peripheral vascular disease?GCST904752204.18
2960CD28 levelsGCST904686164.18
2961Plasma 11beta-hydroxyandrosterone glucuronide levels in chronic kidney diseaseGCST902643214.18
2962DTI autoptx MD slf r tractGCST903852424.18
2963Free Cholesterol to Total Lipids in Medium VLDL percentageGCST904989764.17
2964MEGF9/OXT ratioGCST903154194.17
2965Other embolism and thrombosisFING000010434.17
2966GHR levelsGCST904693424.17
2967SERPINA11 levelsGCST904705804.17
2968SELP/VSIR ratioGCST903158224.16
2969APOM levelsGCST904683424.16
2970WFIKKN1 levelsGCST904710764.16
2971MMP8/PGLYRP1 ratioGCST903154654.16
2972IDS levelsGCST904695074.16
2973Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T145ECGA0001454.15
2974RGCC levelsGCST904704614.14
2975DNAJA2/PRDX5 ratioGCST903145064.14
2976Triacylglycerol_50:2_[M+NH4]1+ levelsGCST900604734.14
2977aparc-Desikan rh volume lateraloccipitalGCST900028114.14
2978CPA2 levelsGCST904688374.14
2979Platelet crit (UKB data field 30090)GCST904680964.14
2980PEAR1/SCARF1 ratioGCST903156424.14
2981FCGR2A/FCGR2B ratioGCST903147934.13
2982IDP dMRI TBSS ICVF Sagittal stratum RGCST900043574.13
2983Total Cholesteryl ester levelsGCST900251884.13
2984Total lipids in IDLGCST904975944.13
2985PEAR1/TREML2 ratioGCST903156454.13
2986Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T17ECGA0000174.12
2987Operative procedures - No procedure performed | Summary OperationsUKBB000005844.12
2988FOLH1 levelsGCST904256614.12
2989IDP dMRI TBSS ISOVF Superior cerebellar peduncle LGCST900044904.12
2990Concentration of medium VLDL particles (UKB data field 23502)GCST902695994.12
2991Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T361ECGU0003614.12
2992CDC37 levelsGCST904686654.12
2993IDP dMRI TBSS OD Superior corona radiata LGCST900044274.12
2994Cardiovascular diseaseGCST900860574.11
2995Cholesterol levels in small LDLGCST900929564.11
2996DTI autoptx FA str r tractGCST903851364.11
2997Thyroid stimulating hormone levels within normal range in pregnancyGCST904351954.11
2998Thyroid stimulating hormone levelsGCST902963334.11
2999Total fatty acid levelsGCST900929874.11
3000Trouble falling asleep when you first go to bedGCST904763854.11